Authors: S. K. Kunutsor, D. Gillatt, A. W. Blom
Notes: Technology with potential
Authors: H. Shiwani, P. Baxter, E. Taylor, M. A. Bailey, D. J. A. Scott
Authors: R. Mouton, C. A. Rogers, R. A. Harris, R. J. Hinchliffe
Notes: Improves 30‐day survival
Long‐term outcomes of endovenous laser ablation and conventional surgery for great saphenous varicose veins.
Authors: T. Wallace, J. El‐Sheikha, S. Nandhra, C. Leung, A. Mohamed, A. Harwood et al.
Notes: EVLA lower recurrence at 5 years
Authors: A. J. A. Meershoek, G. J. de Borst
Predicting risk of rupture and rupture‐preventing reinterventions following endovascular abdominal aortic aneurysm repair. BJS 2018; 105: 1294-1304.
Authors: I. Grootes, J. K. Barrett, P. Ulug, F. Rohlffs, S. J. Laukontaus, R. Tulamo et al.
Notes: Potential to tailor surveillance
Open or endovascular revascularization in the treatment of acute lower limb ischaemia. BJS 2018; 105: 1598-1606.
Authors: O. Grip, A. Wanhainen, K. Michaëlsson, L. Lindhagen, M. Björck
Notes: Endovascular may save lives
Effect of aspirin in vascular surgery in patients from a randomized clinical trial (POISE‐2). BJS 2018; 105: 1591-1597.
Authors: B. M. Biccard, A. Sigamani, M. T. V. Chan, D. I. Sessler, A. Kurz, J. G. Tittley et al.
Notes: No evidence to start or stop aspirin
Authors: P. A. Coughlin, J. H. F. Rudd
Population‐based study of mortality and major amputation following lower limb revascularization. BJS 2018; 105: 1145-1154.
Authors: K. Heikkila, I. M. Loftus, D. C. Mitchell, A. S. Johal, S. Waton, D. A. Cromwell et al.
Notes: lower than previously estimated
Cost‐effectiveness of population‐based vascular disease screening and intervention in men from the Viborg Vascular (VIVA) trial. BJS 2018; 105: 1283-1293.
Authors: R. Søgaard, J. S. Lindholt
Notes: Highly cost‐effective
Five‐year follow‐up of a randomized clinical trial comparing open surgery, foam sclerotherapy and endovenous laser ablation for great saphenous varicose veins. BJS 2018; 105: 686-691.
Authors: S. Vähäaho, K. Halmesmäki, A. Albäck, E. Saarinen, M. Venermo
Notes: More foam recurrences
Eight‐year follow‐up of a randomized clinical trial comparing ultrasound‐guided foam sclerotherapy with surgical stripping of the great saphenous vein. BJS 2018; 105: 692-698.
Authors: Y. L. Lam, J. A. Lawson, I. M. Toonder, N. H. Shadid, A. Sommer, M. Veenstra et al.
Notes: Surgery better
Value of risk scores in the decision to palliate patients with ruptured abdominal aortic aneurysm. BJS 2018; 105: 1135-1144.
Authors: M. J. Sweeting, P. Ulug, J. Roy, R. Hultgren, R. Indrakusuma, R. Balm et al.
Notes: Not much help
Follow‐up after endovascular aortic aneurysm repair can be stratified based on first postoperative imaging. BJS 2018; 105: 709-718.
Authors: H. Baderkhan, O. Haller, A. Wanhainen, M. Björck, K. Mani
Notes: Short sealing zones spell trouble
Risk of major amputation in patients with intermittent claudication undergoing early revascularization. BJS 2018; 105: 699-708.
Authors: J. Golledge, J. V. Moxon, S. Rowbotham, J. Pinchbeck, L. Yip, R. Velu et al.
Notes: Early revascularization associated with amputation
Authors: N. Rudarakanchana, M. P. Jenkins
Notes: Formidable challenge